Humacyte, Inc., together with its subsidiaries, engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its...
43 insider purchases on record · latest filing 2026-08-21.
Insiders have also filed 90 sale transactions at HUMA.